Follow
Paolo Ciracì
Paolo Ciracì
MD - Oncology Resident at University Hospital of Pisa (IT)
Verified email at studenti.uniroma1.it - Homepage
Title
Cited by
Cited by
Year
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
D Rossini, A Boccaccino, M Carullo, C Antoniotti, G Dima, P Ciracì, ...
European Journal of Cancer 184, 106-116, 2023
92023
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group
L Marano, F Marmorino, I Desideri, L Carbone, A Rizzo, V Salvestrini, ...
Frontiers in Nutrition 10, 1045022, 2023
32023
Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: A review of ongoing trials
V Conca, P Ciracì, C Boccaccio, A Minelli, C Antoniotti, C Cremolini
Cancer Treatment Reviews, 102735, 2024
2024
Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer
S Hedayat, L Cascione, D Cunningham, M Schirripa, A Lampis, JC Hahne, ...
Clinical Cancer Research, 2024
2024
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial
MM Germani, G Vetere, M Giordano, P Ciracì, I Capone, E Tamborini, ...
Frontiers in Oncology 13, 1307545, 2024
2024
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile.
A Pretta, P Ziranu, E Perissinotto, P Ciracì, L Giuliani, V Pusceddu, ...
Journal of Clinical Oncology 42 (3_suppl), 195-195, 2024
2024
109P Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular status
A Pretta, P Ziranu, E Perissinotto, P Ciracì, L Giuliani, V Pusceddu, ...
Annals of Oncology 34, S1513, 2023
2023
Next-Generation Sequencing Comparative Analysis of DNA Mutations between Blood-Derived Extracellular Vesicles and Matched Cancer Tissue in Patients with Grade 4 Glioblastoma
P Rosa, E De Falco, L Pacini, A Piazza, P Ciracì, L Ricciardi, F Fiorentino, ...
Biomedicines 10 (10), 2590, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8